UK edtech startup Medly AI has raised $8 million in seed funding to expand its AI-powered exam preparation platform in the UK and international markets. The round was led by Felix Capital, with participation from existing investors Eka Ventures and Ada Ventures. Angel investors Andrey Dobrynin (CEO of InvestEngine), Al Giles (Venture Partner at Creator Fund), Jean Hammond (General Partner at LearnLaunch Accelerator), and Hector Mason (General Partner at Episode 1 Ventures) also participated.
Founded by UCL medicine graduates Dr Paul Jung and Dr Kavi Samra, Medly develops an AI tutor designed to provide personalised academic support for students preparing for exams.
Medly's AI tutor uses a proprietary combination of seven large language models alongside approaches drawn from neuroscience and teaching theory. The system tracks students' progress and learning patterns to adapt its feedback and support to individual users.
Students can use the platform to answer practice questions and receive immediate feedback on their responses, including guidance on where additional marks could be gained. Other features include handwriting recognition, allowing students to complete work directly on the platform using a tablet or stylus, particularly for subjects such as mathematics and chemistry.
Since launching in February 2025, Medly says it has reached more than 400,000 UK users, with students using the platform for around an hour a day on average. The company says students who used the platform for GCSE preparation saw improvements in their results and is conducting a trial with more than 1,000 students to assess its impact on attainment.
Almost a third of 11–16-year-olds receive some form of private tutoring. For those who can afford it, it’s a powerful advantage. For those who can’t, it’s an equally powerful reinforcer of the status quo,
said Dr Paul Jung, co-founder and CEO of Medly. He said the company aims to make personalised academic support more widely accessible by providing students with tutoring that adapts to how they learn.
Medly is also developing proprietary models for specific educational functions, including marking and pedagogy, as well as features aimed at students looking to study beyond standard exam curricula in preparation for higher education.
The company has begun expanding internationally, recently launching SAT preparation in the US, with plans to add AP and ACT support by the end of the year.
The seed funding will be used to grow Medly's student community in the UK, support its international expansion, develop additional AI capabilities and expand its research into the platform's impact on academic outcomes.
Would you like to write the first comment?
Login to post comments